SMTL ID : 5j1w.3 (2 other biounits)

Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW31 (compound 14)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.42 Å

Oligo State

monomer

Ligands

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 3 residues within 4Å: Chain A: H.36, G.39, G.40 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:H.36, A:G.39 GOL.2: 5 residues within 4Å: Chain A: L.98, L.99, G.100, V.152, Q.153 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:L.99 GOL.3: 7 residues within 4Å: Chain A: L.22, L.99, G.100, L.101, S.102, D.105 Ligands: 6FB.5 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.102, A:D.105, A:D.105

1 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.4: 4 residues within 4Å: Chain A: H.190, H.191, S.192, T.193 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.192, A:T.193, A:T.193 Salt bridges: A:H.190

2 x 6FB: pyrido[3,4-g]quinazolin-2-amine(Non-covalent)

6FB.5: 13 residues within 4Å: Chain A: L.22, V.30, A.44, K.46, F.96, E.97, L.98, L.99, G.100, L.150, V.179, D.180 Ligands: GOL.3 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.30, A:V.30, A:F.96, A:V.179, A:V.179 Hydrogen bonds: A:L.99, A:L.99, A:D.180 6FB.6: 7 residues within 4Å: Chain A: N.50, D.52, C.55, R.59, E.87, G.90, I.92 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:I.92 Salt bridges: A:D.52

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Esvan, Y.J. et al., Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure. Eur.J.Med.Chem. (2016)

Release Date

2016-05-04

Peptides

Dual specificity protein kinase CLK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Dual specificity protein kinase CLK1

Related Entries With Identical Sequence